These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 32250317)

  • 1. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
    Poston KL; Ua Cruadhlaoich MAI; Santoso LF; Bernstein JD; Liu T; Wang Y; Rutt B; Kerchner GA; Zeineh MM
    J Parkinsons Dis; 2020; 10(2):591-604. PubMed ID: 32250317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
    Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
    Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Motor Syndrome of Parkinson's Disease.
    Erro R; Stamelou M
    Int Rev Neurobiol; 2017; 132():25-32. PubMed ID: 28554410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
    Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
    J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two motor subtype classifications in de novo Parkinson's disease.
    Choi SM; Kim BC; Cho BH; Kang KW; Choi KH; Kim JT; Lee SH; Park MS; Kim MK; Cho KH
    Parkinsonism Relat Disord; 2018 Sep; 54():74-78. PubMed ID: 29703644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
    Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
    J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardinal Motor Features of Parkinson's Disease Coexist with Peak-Dose Choreic-Type Drug-Induced Dyskinesia.
    Goubault E; Nguyen HP; Bogard S; Blanchet PJ; Bézard E; Vincent C; Langlois M; Duval C
    J Parkinsons Dis; 2018; 8(2):323-331. PubMed ID: 29843253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disentangling Bradykinesia and Rigidity in Parkinson's Disease: Evidence from Short- and Long-Term Subthalamic Nucleus Deep Brain Stimulation.
    Zampogna A; Suppa A; Bove F; Cavallieri F; Castrioto A; Meoni S; Pelissier P; Schmitt E; Chabardes S; Fraix V; Moro E
    Ann Neurol; 2024 Aug; 96(2):234-246. PubMed ID: 38721781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective memory in Parkinson's disease: the role of the motor subtypes.
    D'Iorio A; Maggi G; Vitale C; Amboni M; Di Meglio D; Trojano L; Santangelo G
    J Neurol; 2019 Oct; 266(10):2505-2511. PubMed ID: 31256281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel MRI-based volumetric index for monitoring the motor symptoms in Parkinson's disease.
    Vijayakumari AA; Mandava N; Hogue O; Fernandez HH; Walter BL
    J Neurol Sci; 2023 Oct; 453():120813. PubMed ID: 37742348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mokken scale analysis of the UPDRS: dimensionality of the Motor Section revisited.
    Stochl J; Boomsma A; van Duijn M; Brozová H; Růzická E
    Neuro Endocrinol Lett; 2008 Feb; 29(1):151-8. PubMed ID: 18283252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axial signs and magnetic resonance imaging correlates in Parkinson's disease.
    Acharya HJ; Bouchard TP; Emery DJ; Camicioli RM
    Can J Neurol Sci; 2007 Feb; 34(1):56-61. PubMed ID: 17352348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
    Tarsy D; Scollins L; Corapi K; O'Herron S; Apetauerova D; Norregaard T
    Stereotact Funct Neurosurg; 2005; 83(5-6):222-7. PubMed ID: 16534254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.
    Zhou XX; Li XH; Chen DB; Wu C; Feng L; Chu JP; Yang ZY; Li XB; Qin H; Li GD; Huang HW; Liang YY; Liang XL
    Brain Behav; 2018 May; 8(5):e00930. PubMed ID: 29761003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
    J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology.
    Bartels AL; Leenders KL
    Cortex; 2009 Sep; 45(8):915-21. PubMed ID: 19095226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
    Vu TC; Nutt JG; Holford NH
    Br J Clin Pharmacol; 2012 Aug; 74(2):267-83. PubMed ID: 22283961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.